North America Artificial Retina Market: By Implant Type (Epiretinal Implants, Subretinal Implants), By Disease Type (Retinitis Pigmentosa, Age-related Macular Degeneration, Others), By End Users (Hospitals, Clinics, Ambulatory Surgical Centers), and Country    

Purchase Option

$ 3100
$ 4600
$ 6900

Artificial retina is the medical device consists an array of microelectrodes. North America Artificial Retina Market are implanted into eyes of people those are blind due to the retinal disease. These devices are used in the retinal degenerative disease that causes the damage of photoreceptor cells of retina and leads to complete vision loss. Majorly occurring retinal degenerative diseases include retinitis pigmentosa and age-related macular degeneration. Retinal implants are made up of carbon nanotube biomimetic film with a transmitter and video processing units. These devices restore the vision by capturing light, convert into electrical signals and form an image by stimulating the neurons in retina.Stringent regulatory policies for product approval, Product recall and High R&D expenditure are restraints of North America Artificial Retina Market. This report presents market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. 

 

North America Artificial Retina Market Dynamics

Increase in the prevalence of vision impaired patients, Rise in R&D for the innovation of newer devices and Sophisticated healthcare infrastructure combined with availability of skilled professionals are driving North America Artificial Retina Market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

North America Artificial Retina Market Segmentation

By Implant Type
  • Epiretinal Implants
  • Subretinal Implants
By Disease Type
  • Retinitis Pigmentosa
  • Age-related Macular Degeneration
  • Others
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Frequently Asked Questions

The key segments covered in the North America Artificial Retina Market are: Implant Type, Disease Type, End Users

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1.Executive Summary
2.North America Artificial Retina Market Introduction 
2.1.North America Artificial Retina Market  - Taxonomy
2.2.North America Artificial Retina Market  - Definitions
2.2.1.Implant Type
2.2.2.Disease Type
2.2.3.End Users
2.2.4.Region
3.North America Artificial Retina Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.North America Artificial Retina Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.North America Artificial Retina Market  By Implant Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Epiretinal Implants
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Subretinal Implants
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.North America Artificial Retina Market  By Disease Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Retinitis Pigmentosa
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Age-related Macular Degeneration
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Others
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.North America Artificial Retina Market  By End Users, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinics
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Ambulatory Surgical Centers
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.North America Artificial Retina Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
9.North America Artificial Retina Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Implant Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Epiretinal Implants
9.1.2.Subretinal Implants
9.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Retinitis Pigmentosa
9.2.2.Age-related Macular Degeneration
9.2.3.Others
9.3.  End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinics
9.3.3.Ambulatory Surgical Centers
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Retinitis Pigmentosa
10.2.2.Age-related Macular Degeneration
10.2.3.Others
10.3.  End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinics
10.3.3.Ambulatory Surgical Centers
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Retinitis Pigmentosa
11.2.2.Age-related Macular Degeneration
11.2.3.Others
11.3.  End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinics
11.3.3.Ambulatory Surgical Centers
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Retinitis Pigmentosa
12.2.2.Age-related Macular Degeneration
12.2.3.Others
12.3.  End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinics
12.3.3.Ambulatory Surgical Centers
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Retinitis Pigmentosa
13.2.2.Age-related Macular Degeneration
13.2.3.Others
13.3.  End Users Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinics
13.3.3.Ambulatory Surgical Centers
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Second sight Medical Products, Inc.
14.2.2.Optobionics 
14.2.3.Nidek co. Ltd. 
14.2.4.Aetna Inc. 
15. Research Methodology 
16. Appendix and Abbreviations 

 

  • Second sight Medical Products, Inc.
  • Optobionics 
  • Nidek co. Ltd. 
  • Aetna Inc. 

Adjacent Markets